The scientists Cécile und Oskar Vogt, between them N. W. Timoféeff-Ressovsky
Medical-biological research has a 75-year tradition at Berlin-Buch. Here in 1930 the Institute for Brain Research of the Kaiser Wilhelm Association with the affiliated neurological clinic was established, with Oskar Vogt as director. At that time the institute was the largest and most modern of its kind in the world. Vogt's work focused on histological-anatomic and functional layer- and field structures (topistic) of the cerebral cortex. From 1937 on, Vogt's successor directed the institute's research onto various neuropathological problems including brain tumors. The institute achieved special renown through the work of the Russian geneticist N. W. Timoféeff-Ressovsky on gene mutations and the structure of the gene, in part together with Max Delbrück.
At Work: the geneticist Timoféeff-Ressovsky
In 1947 the institute and clinic were combined as the Institute for Medicine and Biology and placed under the auspices of the German Academy of Sciences in Berlin. The institute became a well-known center for cancer research with research projects on the chemical genesis of cancer, oncogenic viruses, biochemistry, immunology, genetics and radiobiology as well as the clinical treatment of tumors. From 1956 onward, a second emphasis was placed on cardiovascular research, likewise integrating research and clinical practice. In 1972 the different Academy research institutes at Buch merged to form the central institutes for molecular biology, for cancer research and for cardiovascular research.
The former Robert Rössle Hospital, the so-called Tumor Clinic
With the unification of West and East Germany in 1990, the academy institutes were phased out in accordance with the unification agreement. Subsequently, the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch was founded on the Campus in 1992. Starting in 1995, biotechnology companies have settled on the Campus in the Innovation and Founding Center. In 2000 the Leibniz Institute for Molecular Pharmacology (FMP) was established.
Since 2011 the Experimental and Clinical Research Center (ECRC) has been housed in the Robert Rössle Building of the former Tumor Clinic. The ECRC is a joint institution of the Berlin Charité and the Max Delbrück Center with research departments and outpatient clinics of different medical departments.
Building of the Institute for Brain Research of the Kaiser Wilhelm Society, now named after the founders Cécile and Oskar Vogt
News Buch Berlin
Inhibitor of lipid kinase PI3KC2α identified as potential new treatment of thrombosis
The lipid kinase PI3KC2α is a potential pharmacological target for the treatment of thrombosis and, possibly, cancer. Researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)...more ...
Dense and permeable: molecular organization of tight junctions decoded
They seal epithelial cells and, under certain conditions, allow the passage of ions and water: Tight junctions form a paracellular barrier in tissues and their dysfunction is associated with diseases ...more ...
Million euro support for MyoPax
MyoPax, a new spin-off of the Max Delbrück Center and Charité, receives a 1.3 million euros loan to jump-start its entrepreneurial activities. The start-up develops regenerative therapies for previous...more ...
Events Buch Berlin
Sport im Bucher Schlosspark für Senior*innen
Kostenfreies und professionell angeleitetes Bewegungsprogramm im Schlosspark Buchmore ...
Labor trifft Lehrer: Autoimmunkrankheiten der Niere
Die Fortbildungsreihe Labor trifft Lehrer – digital! bietet einmal im Monat biomedizinische Kurse zur aktuellen Forschung für Lehrerinnen und Lehrer an. Diese finden unter der Leitung von Forschungsgr...more ...
Offener Pilateskurs für alle Nachbarinnen und Nachbarn
Gmeinsam Sport treiben und sich austauschenmore ...